• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
BCDA

BCDA

BioCardia, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.87

-0.03 (-2.84%)

Rating:C+

Company Profile

CEO

Peter A. Altman

IPO Date

1996-11-13

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.90

Prev. Close

$0.90

Day Low

$0.87

Day High

$0.90

52W Low

$0.84

52W High

$2.45

Market Cap

$0.01B

Volume

0.20M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

18.6%

Avg Negative

2.3%

Avg Neutral

79.0%

News Feed

BioCardia to Participate in Upcoming Investor Conferences

GlobeNewsWire·8/13/2021·↑ positive

BioCardia Reports Second Quarter 2021 Financial Results and Business Highlights

GlobeNewsWire·8/12/2021·↓ negative

Will BioCardia, Inc. (BCDA) Report Negative Q2 Earnings? What You Should Know

Zacks Investment Research·8/5/2021·↑ positive

BioCardia Announces Japanese Patent on Imaging System for Targeting Cardiac Therapies

GlobeNewsWire·7/15/2021·↑ positive

Why I've Taken A Small Position In BioCardia

Seeking Alpha·6/14/2021·↑ positive

BioCardia, Inc. (BCDA) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research·5/13/2021·↑ positive

BioCardia, Inc. (BCDA) Reports Q4 Loss, Misses Revenue Estimates

Zacks Investment Research·3/30/2021·↑ positive

BioCardia Announces Clinical Leadership Changes

GlobeNewsWire·2/17/2021·↑ positive

BioCardia Update on Cell Therapy Product Development and 2021 Milestones

GlobeNewsWire·2/2/2021·↑ positive

Accomplished Biotech Executive Krisztina Zsebo, Ph.D. Joins BioCardia's Board of Directors

GlobeNewsWire·1/11/2021·↑ positive